Dose Approach Matter? A Meta-analysis of Outcomes Following Transfemoral Versus Transapical Transcatheter Aortic Valve Replacement

Overview

Journal BMC Cardiovasc Disord

Publisher Biomed Central

Specialty Cardiology & Vascular Diseases

Date 2021 Jul 29

PMID 34320946

Citations 10

Authors

Ruikang Guo

Minghui Xie

Wai Yen Yim

Wenconghui Wu

Weiwei Jiang

Yin Wang

Xingjian Hu

Affiliations

Soon will be listed here.

Abstract

Background: Transcatheter aortic valve replacement (TAVR) has gained increasing acceptance for patients with aortic disease. Both transfemoral (TF-TAVR) and transapical (TA-TAVR) approach were widely adopted while their performances are limited to a few studies with controversial results. This meta-analysis aimed to compare the mortality and morbidity of complications between TF- versus TA-TAVR based on the latest data.

Methods: Electronic databases were searched until April 2021. RCTs and observational studies comparing the outcomes between TF-TAVR versus TA-TAVR patients were included. Heterogeneity assumption was assessed by an I test. The pooled odds ratios(OR) or mean differences with corresponding 95% confidence intervals (CI) were used to evaluate the difference for each end point using a fixed-effect model or random-effect model based on I test.

Results: The meta-analysis included 1 RCT and 20 observational studies, enrolling 19,520 patients (TF-TAVR, n = 11,986 and TA-TAVR, n = 7,534). Compared with TA-TAVR, TF-TAVR patients showed significantly lower rate of postoperative in-hospital death (OR = 0.67, 95% CI 0.59-0.77, P < 0.001) and 1-year death (OR = 0.53, 95% CI 0.41-0.69, P < 0.001). Incidence of major bleeding and acute kidney injury were lower and length of hospital stay was shorter, whereas those of permanent pacemaker and major vascular complication were higher in TF-TAVR patients. There were no significant differences between TF-TAVR versus TA-TAVR for stroke and mid-term mortality.

Conclusions: There were fewer early deaths in patients with transfemoral approach, whereas the number of mid-term deaths and stroke was not significantly different between two approaches. TF-TAVR was associated with lower risk of bleeding, acute kidney injury as well as shorter in-hospital stay, but higher incidence of vascular complication and permanent pacemaker implantation.

Citing Articles

Outcomes of transcatheter aortic valve implantation for native aortic valve regurgitation.

Le Ruz R, Leroux L, Lhermusier T, Cuisset T, Van Belle E, Dibie A EuroIntervention. 2024; 20(17):e1076-e1085.

PMID: 39219361 PMC: 11363660. DOI: 10.4244/EIJ-D-24-00339.

Exploring Optimal Strategies for Surgical Access in Transcatheter Aortic Valve Implantation.

Purmessur R, Ahmed Z, Ali J J Clin Med. 2024; 13(16).

PMID: 39200796 PMC: 11354912. DOI: 10.3390/jcm13164655.

Trans-femoral versus trans-carotid access for transcatheter aortic valve replacement: an updated systematic review and meta-analysis.

Yamani N, Ali S, Sadiq M, Ahmed A, Bhojwani K, Lohana V Future Sci OA. 2024; 10(1):FSO930.

PMID: 38817364 PMC: 11137775. DOI: 10.2144/fsoa-2023-0101.

Risk Factors, Management, and Avoidance of Conduction System Disease after Transcatheter Aortic Valve Replacement.

Alabdaljabar M, Eleid M J Clin Med. 2023; 12(13).

PMID: 37445439 PMC: 10342285. DOI: 10.3390/jcm12134405.

Cerebral ischemic injury after transcatheter aortic valve replacement in patients with pure aortic regurgitation.

Liu X, Dai H, Fan J, Zhou D, Zhu G, Yidilisi A J Zhejiang Univ Sci B. 2023; 24(6):530-538.

PMID: 37309044 PMC: 10264174. DOI: 10.1631/jzus.B2200444.

References

Holmes Jr D, Nishimura R, Grover F, Brindis R, Carroll J, Edwards F . Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry. Ann Thorac Surg. 2016; 101(2):789-800. DOI: 10.1016/j.athoracsur.2015.10.049. View

Al-Attar N, Himbert D, Descoutures F, Iung B, Raffoul R, Messika-Zeitoun D . Transcatheter aortic valve implantation: selection strategy is crucial for outcome. Ann Thorac Surg. 2009; 87(6):1757-62. DOI: 10.1016/j.athoracsur.2009.03.047. View

Rodes-Cabau J, Gutierrez M, Bagur R, De LaRochelliere R, Doyle D, Cote M . Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation. J Am Coll Cardiol. 2011; 57(20):1988-99. DOI: 10.1016/j.jacc.2010.11.060. View

Ghatak A, Bavishi C, Cardoso R, Macon C, Singh V, Badheka A . Complications and Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement With Edwards SAPIEN & SAPIEN XT Valves: A Meta-Analysis of World-Wide Studies and Registries Comparing the Transapical and Transfemoral Accesses. J Interv Cardiol. 2015; 28(3):266-78. DOI: 10.1111/joic.12201. View

Thomas M, Schymik G, Walther T, Himbert D, Lefevre T, Treede H . Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010; 122(1):62-9. DOI: 10.1161/CIRCULATIONAHA.109.907402. View

Arai T, Romano M, Lefevre T, Hovasse T, Farge A, Le Houerou D . Direct Comparison of Feasibility and Safety of Transfemoral Versus Transaortic Versus Transapical Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2016; 9(22):2320-2325. DOI: 10.1016/j.jcin.2016.08.009. View

Cumpston M, Li T, Page M, Chandler J, Welch V, Higgins J . Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019; 10:ED000142. PMC: 10284251. DOI: 10.1002/14651858.ED000142. View

Koifman E, Magalhaes M, Kiramijyan S, Escarcega R, Didier R, Torguson R . Impact of transfemoral versus transapical access on mortality among patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Cardiovasc Revasc Med. 2016; 17(5):318-21. DOI: 10.1016/j.carrev.2016.05.002. View

Al-Hijji M, Zack C, Nkomo V, Pislaru S, Pellikka P, Reeder G . Left ventricular remodeling and function after transapical versus transfemoral transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2019; 94(5):738-744. DOI: 10.1002/ccd.28074. View

10.

Blackstone E, Suri R, Rajeswaran J, Babaliaros V, Douglas P, Fearon W . Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy. Circulation. 2015; 131(22):1989-2000. DOI: 10.1161/CIRCULATIONAHA.114.012525. View

11.

Auffret V, Lefevre T, Van Belle E, Eltchaninoff H, Iung B, Koning R . Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVI. J Am Coll Cardiol. 2017; 70(1):42-55. DOI: 10.1016/j.jacc.2017.04.053. View

12.

Corbett M, Higgins J, Woolacott N . Assessing baseline imbalance in randomised trials: implications for the Cochrane risk of bias tool. Res Synth Methods. 2015; 5(1):79-85. DOI: 10.1002/jrsm.1090. View

13.

Panchal H, Ladia V, Amin P, Patel P, Veeranki S, AlBalbissi K . A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events in patients undergoing transfemoral versus transapical transcatheter aortic valve implantation using edwards valve for severe aortic stenosis. Am J Cardiol. 2014; 114(12):1882-90. DOI: 10.1016/j.amjcard.2014.09.029. View

14.

Eltchaninoff H, Prat A, Gilard M, Leguerrier A, Blanchard D, Fournial G . Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J. 2010; 32(2):191-7. DOI: 10.1093/eurheartj/ehq261. View

15.

Dworakowski R, MacCarthy P, Monaghan M, Redwood S, El-Gamel A, Young C . Transcatheter aortic valve implantation for severe aortic stenosis-a new paradigm for multidisciplinary intervention: a prospective cohort study. Am Heart J. 2010; 160(2):237-43. DOI: 10.1016/j.ahj.2010.05.014. View

16.

Bagur R, Webb J, Nietlispach F, Dumont E, De LaRochelliere R, Doyle D . Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J. 2009; 31(7):865-74. PMC: 2848323. DOI: 10.1093/eurheartj/ehp552. View

17.

Ewe S, Delgado V, Ng A, Antoni M, van der Kley F, Ajmone Marsan N . Outcomes after transcatheter aortic valve implantation: transfemoral versus transapical approach. Ann Thorac Surg. 2011; 92(4):1244-51. DOI: 10.1016/j.athoracsur.2011.01.059. View

18.

Siontis G, Praz F, Pilgrim T, Mavridis D, Verma S, Salanti G . Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials. Eur Heart J. 2016; 37(47):3503-3512. DOI: 10.1093/eurheartj/ehw225. View

19.

Thourani V, Kodali S, Makkar R, Herrmann H, Williams M, Babaliaros V . Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016; 387(10034):2218-25. DOI: 10.1016/S0140-6736(16)30073-3. View

20.

Liberati A, Altman D, Tetzlaff J, Mulrow C, Gotzsche P, Ioannidis J . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009; 339:b2700. PMC: 2714672. DOI: 10.1136/bmj.b2700. View